Delivery Order SPE2DB24D9155-SPE2DB25FHZHH
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for IOSAT 130 mg tablets (14-count packaging). This firm fixed-price delivery order, valued at $1,612.80, was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The order carries no set-aside designation and represents a purchase of potassium iodide tablets, which are used for thyroid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,612.80 by the Defense Logistics Agency on August 15, 2025. The delivery order, which is for Iosatâ„¢ 130 mg tablets (14-count packaging), is scheduled for completion by August 18, 2025, with performance taking place at the contractor's Park Ridge facility. This award was made without a set-aside designation, allowing DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price model with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,832.75 to DMS Pharmaceutical Group Inc. for IOSAT 130 mg tablets (14-count packaging) on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to supply this...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,612.80 by the Defense Logistics Agency on August 12, 2025, for IOSAT 130 mg tablets (14-count package). This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, valued at approximately $500 million and...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract worth $13,708.97 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of IOSAT 130 MG TABLET 14S, with a completion date of February 12, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the SPE2DB program, which has a total potential...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,027.10 firm fixed-price delivery order is for the supply of IOSAT 130 MG TABLET 14S, a pharmaceutical product, with an ultimate completion date of October 11, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,466.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 27, 2024, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,199.30 firm fixed-price contract is for the delivery of IOSAT 130 MG TABLET 14S pharmaceuticals, with a completion date of February 6, 2024. The contract is not set aside. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that has received numerous prime and subcontract awards from...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $7,844.17 firm fixed-price delivery order for the supply of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a performance period ending on December 6, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB24D9155Indefinite Delivery Contract
- SPE2DB24D9155-SPE2DB25FHZHHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,612.80 to DMS Pharmaceutical Group Inc. for IOSAT 130 mg tablets (14-count packaging) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA, valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of delivery orders from the Defense Logistics Agency, covering an extensive array of prescription medications, biologics, and medical consumables. The company's ability to compete effectively in federal procurement markets without specific set-aside designations, despite its woman-owned small business status, reflects its competitive positioning and capacity to deliver specialized pharmaceutical products to Department of Defense healthcare sites. IOSAT, a potassium iodide product used for radiation emergency preparedness, represents the type of essential pharmaceutical inventory that the DLA maintains to support military medical readiness and personnel protection requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/8/25 |